Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
247 participants
OBSERVATIONAL
2018-03-23
2022-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Fetal Growth and Placental Function in Pregnancies Complicated by Diabetes
NCT04801121
Placental Growth and Adverse Pregnancy Outcomes
NCT01669525
Study of Placental Inflammation in Gestational Diabetes
NCT06884696
Fetus Programming and Long Active Outcomes, Interaction Between Mother, Placenta and Fetus in Perinatal and Methabolic Disbalansces-focusing Diabetic Pregnancies
NCT07337759
The Use of the CPR to Predict Adverse Outcomes in GDM Pregnancies
NCT03072563
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
normal weight without gestational diabetes
BMI \< 25; normal glucose tolerance
no intervention
no intervention
normal weight with gestational diabetes
BMI \< 25; impaired oral glucose tolerance
no intervention
no intervention
overweight without gestational diabetes
BMI 25 - 29.9; normal glucose tolerance
no intervention
no intervention
overweight with gestational diabetes
BMI 25 - 29.9; impaired glucose tolerance
no intervention
no intervention
obese without gestational diabetes
BMI \>= 30; normal glucose tolerance
no intervention
no intervention
obese with gestational diabetes
BMI \>= 30; impaired glucose tolerance
no intervention
no intervention
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
no intervention
no intervention
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* BMI before pregnancy \>= 18
* with \& without gestational diabetes
* c-section at gestational week 35+0 until 41+6
Exclusion Criteria
* maternal serious internal disease
* infections before pregnancy (e.g. HIV, hepatitis B)
* pregnancy-associates diseases (e.g. gestoses, androgen insensitivity syndrome)
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sarah Appel
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sarah Appel
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sarah Appel, Dr.
Role: PRINCIPAL_INVESTIGATOR
Universitätsklinikum Köln
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital of Cologne
Cologne, North Rhine-Westphalia, Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
14-244
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.